Journal article
Authors list: Korosec, Peter; Jakob, Thilo; Harb, Harfi; Heddle, Robert; Karabus, Sarah; Zollner, Ricardo de Lima; Selb, Julij; Thong, Bernard Yu-Hor; Zaitoun, Fares; Golden, David B. K.; Levin, Michael
Publication year: 2019
Journal: World Allergy Organization Journal
Volume number: 12
Issue number: 10
ISSN: 1939-4551
Open access status: Gold
DOI Link: https://doi.org/10.1016/j.waojou.2019.100067
Publisher: Elsevier
Abstract:
Venom immunotherapy is the standard of care for people with severe reactions and has been proven to reduce risk of future anaphylactic events. There is a moral imperative to ensure production, supply and worldwide availability of locally relevant, registered, standardized commercial venom extracts for diagnosis and treatment. Insects causing severe immediate allergic reactions vary by region worldwide. The most common culprits include honeybees (Apis mellifera), social wasps including yellow jackets (Vespula and Dolichovespula), paper wasps (Polistes) and hornets (Vespa), stinging ants (Solenopsis, Myrmecia, Pachycondyla, and Pogonomyrmex), and bumblebees (Bombus). Insects with importance in specific areas of the world include the Australian tick (Ixodes holocyclus), the kissing bug (Triatoma spp), horseflies (Tabanus spp), and mosquitoes (Aedes, Culex, Anopheles). Reliable access to high quality venom immunotherapy to locally relevant allergens is not available throughout the world. Many current commercially available therapeutic vaccines have deficiencies, are not suitable for, or are unavailable in vast areas of the globe. New products are required to replace products that are unstandardized or inadequate, particularly whole-body extract products. New products are required for insects in which no current treatment options exist. Venom immunotherapy should be promoted throughout the world and the provision thereof be supported by health authorities, regulatory authorities and all sectors of the health care service.
Citation Styles
Harvard Citation style: Korosec, P., Jakob, T., Harb, H., Heddle, R., Karabus, S., Zollner, R., et al. (2019) Worldwide perspectives on venom allergy, World Allergy Organization Journal, 12(10), Article 100067. https://doi.org/10.1016/j.waojou.2019.100067
APA Citation style: Korosec, P., Jakob, T., Harb, H., Heddle, R., Karabus, S., Zollner, R., Selb, J., Thong, B., Zaitoun, F., Golden, D., & Levin, M. (2019). Worldwide perspectives on venom allergy. World Allergy Organization Journal. 12(10), Article 100067. https://doi.org/10.1016/j.waojou.2019.100067
Keywords
ANAPHYLACTIC REACTIONS; ANT SOLENOPSIS-INVICTA; IGE ANTIBODIES; IMMUNOTHERAPY; MAJOR ALLERGENS; MOSQUITO ALLERGY; NATURAL-HISTORY; PACHYCONDYLA-CHINENSIS; POLYBIA-PAULISTA HYMENOPTERA; STING ANAPHYLAXIS; SYSTEMIC REACTIONS; venom immunotherapy